first large study of glp 1 receptor agonists during pregnancy Glucagon-like peptide-1 receptor: mechanisms and advances in therapy PDF) Use of GLP1 receptor
Description
Liu L, Su X, Quinn WJ, Hui S, Krukenberg K, Frederick DW, et al

sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study
Berger J

Multiple other molecules (including combinations of entero-pancreatic hormones and oral GLP-1 RA) are in late phase clinical trials as potential obesity treatments, leading to WL that approaches the efficacy of bariatric surgery [101]
(Another DPP-4 inhibitor, vildagliptin, is widely prescribed in Europe but is not available in the U.S.) These agents are also available in combination with other diabetes medications (i.e., metformin, empagliflozin, pioglitazone, dapagliflozin, ertugliflozin)
